Esophageal subepithelial lesion diagnosed as malignant gastrointestinal neuroectodermal tumor.
Kim SB, Lee SH, Gu MJ.
World J Gastroenterol. 2015 May 14;21(18):5739-43. doi: 10.3748/wjg.v21.i18.5739.
PMID:25987801
Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery.
Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Ohsawa M, Hirohata R, Kitasaki N, Okada M.
High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation.
Van Dam J, Rice TW, Catalano MF, Kirby T, Sivak MV Jr.
Cancer. 1993 May 15;71(10):2910-7. doi: 10.1002/1097-0142(19930515)71:10<2910::aid-cncr2820711005>3.0.co;2-l.
PMID:8490818
Epithelioid malignant mesothelioma presenting with features of esophageal tumor.
Khalil MW, Campbell AP, Cowen ME.
Asian Cardiovasc Thorac Ann. 2011 Jun;19(3-4):260-1. doi: 10.1177/0218492311406748.
PMID:21885553
Malignant Esophageal Glomus Tumor With CARMN::NOTCH2 Fusion: An Additional Tumor Underscoring the Frequent Tendency of Esophageal Glomus Tumors for Aggressive Behavior.
Pancsa T, Martínek P, Michal M.
Int J Surg Pathol. 2025 Jun;33(4):987-991. doi: 10.1177/10668969241291887. Epub 2024 Nov 10.
PMID:39523591
Prognostic biomarkers for immunotherapy in esophageal cancer.
Tong X, Jin M, Wang L, Zhang D, Yin Y, Shen Q.
Front Immunol. 2024 Sep 30;15:1420399. doi: 10.3389/fimmu.2024.1420399. eCollection 2024.
PMID:39403382
Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery.